Evaluating the Feasibility of Collecting User Interaction Data at the Emory Autism Center Using MapHabit Software
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-24
SponsorEmory University
About this trial
The purpose of this study is to evaluate the impact of the MapHabit System on autistic transition-age youth (ages 18-24) as they navigate key life transitions including graduating from high school, entering adult services, pursuing employment or education, and community-based living.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 -24 years old at time of enrollment
Documented diagnosis of Autism, confirmed through prior clinical evaluation and diagnostic reports
Ability to provide informed consent independently or availability of legally authorized representative
Disqualifiers
Children
Inability to provide consent or lack of availability of a legally authorized representative
Active crisis requiring intensive intervention
Trial design
Design model
Single group
Treatments tested in this trial
MapHabit System (MHS)
BehavioralThe MapHabit System (MHS) is a commercially available visual mapping software application that utilizes visual, audio, and text media to create step-by-step visual guides to help participants accomplish activities of daily living (ADL) and build independent habits. The goal of the application is to develop and facilitate habits and routines using structured visual and auditory stimuli that can be customized by the user and can include educational and lesson-based material in addition to ADLs. It will be delivered using mobile application (iOS/Android tablets provided to participants) and/or printed materials.
Treatment groups
140 Participants
are divided into 1 treatment groupGroup A: MapHabit System ArmExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
World Health Organization Quality of Life Brief Version (WHOQOL-BREF) Score
Quality of life as assessed by the WHOQOL-BREF, a 26-item self-report questionnaire measuring physical health, psychological health, social relationships, and environmental domains. Domain scores are transformed to a scale ranging from 0 to 100, with higher scores indicating better quality of life.
Time frame
Baseline, 3 and 6 months post-intervention2
Depression Anxiety Stress Scales-21 (DASS-21) Score
Psychological distress as assessed by the DASS-21, a 21-item self-report measure of depression, anxiety, and stress symptoms. Total scores range from 0 to 63, with higher scores indicating greater psychological distress and symptom severity.
Time frame
Baseline, 3 and 6 months post-intervention3
Modified American Institutes for Research (AIR) Self-Determination Scale Total Score
Assessed by a modified AIR Self-Determination Scale evaluating self-determination capacity and opportunity, including autonomy, self-regulation, psychological empowerment, and goal-directed behavior, with additional items related to employment and educational outcomes. The overall self-determination score is reported as a percentage from 0% to 100%, with higher scores indicating greater self-determination.
Time frame
Baseline, 3 and 6 months post-intervention4
Number of participants based on Vocational and Educational Participation Status
Participation in employment, vocational training, educational programs, volunteer activities, and other structured weekly activities as assessed by a vocational and educational interview. This outcome includes the number of participants engaged in each activity category at the assessment time point.
Time frame
Baseline, 3 and 6 months post-interventionSecondary outcomes
1
MapHabit Application Use Frequency
Frequency of visual map use will be reported per participant by MapHabit system analytics. Higher values indicate greater use of the intervention.
Time frame
Baseline, 3 and 6 months post-intervention2
MapHabit Activity Adherence
Adherence to planned activities supported by the MapHabit application as measured by MapHabit system analytics. Adherence will be assessed based on participant completion and use patterns recorded within the platform. Higher adherence values indicate greater engagement with intervention-related activities.
Time frame
Baseline, 3 and 6 months post-intervention3
Number of Maps Accessed or Created in MapHabit
Participant engagement with the MapHabit system as measured by the total number of visual maps created and/or accessed during the study period, as captured through automated backend analytics. Higher values indicate greater platform utilization.
Time frame
Baseline, 3 and 6 months post-intervention4
Time Spent Using the MapHabit Application
Total duration of use of the MapHabit application during the study period, measured through automated backend analytics and reported in minutes per day.
Time frame
Baseline, 3 and 6 months post-interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: